Atlas One · Host Biology · Scale 07 — System

Synovial Sarcoma

Synovial sarcoma is defined by SS18-SSX1/SSX2 fusion (t(X;18)) → SMARCB1 displacement from BAF → EZH2 dependency; ~800/year USA; biphasic/monophasic histology; TLE1 IHC positive; ifosfamide-based chemotherapy; tazemetostat (SARC057 ORR ~22%) and trabectedin active.

Also known as: synovial sarcoma, SS18-SSX sarcoma, biphasic synovial sarcoma, monophasic synovial sarcoma, t(X;18) sarcoma, TLE1-positive sarcoma, translocation sarcoma SYT-SSX, synovial cell sarcoma

Scale 07 — SystemScale
draftStatus
2026-06-06Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
synovial-sarcoma

Synovial Sarcoma

Synovial sarcoma is defined by SS18-SSX1/SSX2 fusion (t(X;18)) → SMARCB1 displacement from BAF → EZH2 dependency; ~800/year USA; biphasic/monophasic histology; TLE1 IHC positive; ifosfamide-based chemotherapy; tazemetostat (SARC057 ORR ~22%) and trabectedin active.